NEXUS BIOQUEST LIMITED
Company number 14131243 · Monitor this company
Executive summary
Nexus Bioquest Limited is a small but growing biotech research company with solid liquidity and equity backing, supported by timely statutory compliance and an unqualified audit. Despite operational losses increasing retained deficits and a notable rise in trade debtors, the company maintains strong short-term financial health. Further investigation into profitability drivers and cash flow management is recommended to fully assess long-term sustainability.
Shareholders' funds
£4,303,005
Balance sheet as at 2025-09-30
Overview
- Company type
- Private Limited Company
- Incorporated
- 2022-05-25
- Employees
- 34 (2025 accounts · was 28 in 2024)
- Registered office
- 9th Floor 107 Cheapside, London, United Kingdom, EC2V 6DN
- Postcode
- EC2V 6DN
- Accounts category
- Small
Accounts
- Last made up to
- 2025-09-30
- Next due by
- 2027-06-30
- Financial year end
- 30 September
Confirmation statement
- Last statement dated
- 2026-05-24
- Next due by
- 2027-06-07
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 8 current · 1 resigned
Data protection registration
Registered with the ICO as a data protection fee payer — ZB369885 (Tier 2), registered since 2022.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- nexusbioquest.com
Nexus BioQuest - immunology CRO providing contract research services for immune-oncology, autoimmunity & inflammation. Accelerate to clinic.
Among its peers
Top 5%
by shareholders' funds, of 138 similar companies in EC
Among the biggest employers among its local peers (34 staff).
Trading since 2022.
No.6 of the largest research and experimental development on biotechnology companies in London →
Competitors London
This company ranks 6 among research and experimental development on biotechnology in London.